Tommi Unkuri

Investor | Boards | Advisor to Summa Equity

📍 Stockholm County, Sweden🔄 Updated September 2026💼 12 investments📅 9 years investing🗓 Last invested Jun 2023
VC🌍 Sweden
12
Total investments
0
Early stage
1
Mid stage
2
Late stage
9y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jun 2023
Sciety is a leading investment company, committed to supporting the growth of innovative life science and health tech companies in the Nordic region. We invest alongside Sciety Venture Partners, comprising family offices and private investors, as well as venture capital firms. Our mission is to enable the full potential of life science innovations, helping to bring breakthroughs in healthcare to people all over the world.
Board Member
Jul 2022
Velsera connects healthcare and life sciences to reveal the true promise of precision medicine — a continuous flow of knowledge between researchers, scientists, and clinicians around the world, fueling innovation and creating insights that radically improve human health. Our goal is to use data to radically improve healthcare globally and create value through multiomics and insights. If you’re interested in learning more about Velsera, please follow us and visit our website at velsera.com! Looking for someone to get in touch with? Please email hello@velsera.com
Board Member
Oct 2018
Turning data into better healthcare, that is our mission. We empower stakeholders at every level of the healthcare system by bringing clarity to decisions that result into the best possible healthcare. LOGEX is headquartered in Amsterdam, with over 350 international experts working in ten countries across Europe. To learn how LOGEX can bring clarity to your healthcare data, visit logex.com.
Board Member
Apr 2017
Turning data into better healthcare We transform healthcare data into actionable insights to help decision-makers, regulators and clinicians optimise the healthcare they provide. LOGEX is headquartered in Amsterdam, with over 400 international experts working in ten countries across Europe. To learn how LOGEX can bring clarity to your healthcare data, visit logex.com.
Board Member
Apr 2017
We empower stakeholders at every level of the healthcare system by bringing clarity to decisions that result into the best possible healthcare. LOGEX is headquartered in Amsterdam, with over 350 international experts working in ten countries across Europe. To learn how LOGEX can bring clarity to your healthcare data, visit logex.com.
Board Member
Feb 2017
Lin Education is the market leader in Sweden with 200,000 digital tools in over 60 Swedish municipalities. Not only offering digital tools to the educational market, but also striving to be a leader in the development of learning content. We are passionate about making a difference! Visit us at Bett Show in January in London!
Experience · 15 entries
All (15)
Investments (12)
Board (12)
2023
Board Member
Jun 2023
Sciety is a leading investment company, committed to supporting the growth of innovative life science and health tech companies in the Nordic region. We invest alongside Sciety Venture Partners, comprising family offices and private investors, as well as venture capital firms. Our mission is to enable the full potential of life science innovations, helping to bring breakthroughs in healthcare to people all over the world.
2022
Board Member
Jul 2022
Velsera connects healthcare and life sciences to reveal the true promise of precision medicine — a continuous flow of knowledge between researchers, scientists, and clinicians around the world, fueling innovation and creating insights that radically improve human health. Our goal is to use data to radically improve healthcare globally and create value through multiomics and insights. If you’re interested in learning more about Velsera, please follow us and visit our website at velsera.com! Looking for someone to get in touch with? Please email hello@velsera.com
2021
Board Member
Jul 2021
Axion BioSystems’ suite of live-cell analysis tools offers next-generation solutions for continuous, noninvasive monitoring of in vitro cell models on your benchtop or inside your incubator. From investigating disease mechanisms in neurology and cardiology to developing lifesaving immunotherapies and antivirals, Axion’s award-winning products are designed to accelerate scientific breakthroughs and transform therapeutic development from discovery to manufacturing.   Since launching the revolutionary Maestro multielectrode array (MEA) system in 2008, Axion has continuously expanded its offerings, introducing the premier live-cell analyzer Maestro Z in 2019 and the automated live-cell Omni imager in 2023. Featuring real-time, label-free monitoring, powerful software, and scalable throughput, discover how Axion’s user-friendly tools can simplify the workflow in any academic, biotechnology, or pharmaceutical lab.   Promoting a culture of collaboration, innovation, inclusivity, and customer commitment, Axion BioSystems has more than 180 employees worldwide and is headquartered in the tech hub of Atlanta, Georgia, USA. 
Board Member
Jul 2021
G-CON Manufacturing, Inc.’s prefabricated, turnkey cleanroom systems represent a significant transition to forward thinking in pharmaceutical and biopharmaceutical processing. G-CON Manufacturing, the innovator of autonomous cleanroom PODs, turned the challenges experienced by the biopharmaceutical industry into readily deployable, flexible, mobile and scalable cleanroom solutions. PODs are ideal for multi-product sites, rigorous containment needs, and on demand scaling of production and laboratory space. Building on its first design in 2009, G-CON now has a wide array of cleanroom PODs in their product portfolio to accommodate the increased demand from the pharmaceutical, biopharmaceutical and cell therapeutic industries. Moreover, G-CON’s patent portfolio continues to grow which will effectively preclude imitators from copying G-CON’s initial and more recent innovations. At G-CON, we will continue to evolve and grow with the industry to provide a comprehensive cleanroom solution that truly is flexible, scalable and fast, all for a fair and known price from the time the contract is signed.
2020
Board Member
Oct 2020
Sengenics is a functional proteomics company that leverages its patented KREX protein folding technology to discover autoantibody biomarker signature for drug response prediction, patient stratification and development of companion diagnostics. Our technology ensure that all microarray proteins are full length, correctly folded and functional, enabling specific and quantitative antibody binding to conformational epitopes. The company has a global footprint with multiple corporate and research sites across the world with customers and collaborators that include top pharma, biotech and ivy league academic institutions in North America, Europe, and Asia.
Show all 15 entries ↓
Investment activity
2017–2023 · 12 investments
20174201822019120201202122022120231
Recent (last 2 years)Earlier